Copenhagen, Denmark

Preben H Olesen

This inventor holds 57 USPTO granted patents, plus 3 CIPO patents, primarily in Heterocyclic Compounds (CPC class 5143). Top assignees: Novo Nordisk A/s, Pronova Biopharma Norge as, High Point Pharmaceuticals, LLC. Active years: 1991-2026.


% Patents Active = 91.2

 

Average Co-Inventor Count = 2.5

ph-index = 10

Forward Citations = 415(Granted Patents)

Forward Citations (Not Self Cited) = 328(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Kobenhavn NV, DK (1996)
  • 2400 K.o slashed.benhavn NV, DK (1997)
  • K.o slashed.benhavn NV, DK (1997 - 1998)
  • Kbh. NV, DK (1998)
  • K.o slashed.benhavn, DK (1996 - 1999)
  • Coppenhagen NV, DK (1999)
  • Kobenhavn, DK (1993 - 2011)
  • København NV, DK (2022)
  • Copenhagen, DK (1991 - 2023)

Company Filing History:


Years Active: 1991-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Heterocyclic Compounds
Fatty Acid Oil Mixtures
Lipid Compositions
Surfactants
Obesity Treatment
Diabetes Treatment
Pyridinyl Thiadiazolyl
Antipsychotic Method
Triglycerides
Free Fatty Acids
Coated Capsules
Pharmacological Derivatives
57 patents (USPTO):Explore Patents

Title: Innovations by Preben H Olesen: Pioneering Fatty Acid Compositions

Introduction

Preben H Olesen, based in Copenhagen, Denmark, is an accomplished inventor known for his significant contributions to innovations in drug delivery systems and food supplements. With a remarkable portfolio of 56 patents, Olesen continues to push the boundaries of science and technology through his creative inventions.

Latest Patents

Among his latest inventions are groundbreaking patents focused on compositions that involve fatty acid oil mixtures and surfactants. One notable patent involves a preconcentrate containing a fatty acid oil mixture rich in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), preferably in the forms of ethyl ester or triglyceride, combined with at least one surfactant. This innovation enables the formation of advanced drug delivery systems such as self-nanoemulsifying (SNEDDS), self-microemulsifying (SMEDDS), or self-emulsifying drug delivery systems (SEDDS) in aqueous solutions. Additionally, Olesen has developed compositions that incorporate a fatty acid oil mixture and free fatty acids, further enhancing the capabilities of these delivery systems.

Career Highlights

Preben H Olesen has had an impressive career, having contributed his expertise to esteemed companies like Novo Nordisk A/S and Pronova Biopharma Norge AS. His extensive work in these organizations has not only advanced his own understanding and innovation but also played a pivotal role in the development of state-of-the-art solutions in healthcare and nutrition.

Collaborations

Throughout his career, Olesen has collaborated with notable professionals, including Per Sauerberg and Svein Olaf Hustvedt. Working alongside such esteemed colleagues has likely enriched his perspectives and pushed the boundaries of innovation within the industry.

Conclusion

Preben H Olesen stands out as a prolific inventor with a profound impact on drug delivery systems and nutritional supplements. His latest patents reflect a deep understanding of fatty acid compositions and their applications, reinforcing his status as a leading figure in the world of innovations. His work, especially in collaboration with other experts, continues to influence and inspire advancements in both pharmaceuticals and dietary solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…